Valneva SE (VLA.PA)
EUR 2.91
(0.62%)
EUR 2.91
(0.62%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.73 EUR | 41.13% |
| 2022 | -1.24 EUR | -65.33% |
| 2021 | -0.75 EUR | -5.63% |
| 2020 | -0.71 EUR | -3636.84% |
| 2019 | -0.02 EUR | -146.91% |
| 2018 | 0.04 EUR | 127.0% |
| 2017 | -0.15 EUR | 77.27% |
| 2016 | -0.66 EUR | -135.71% |
| 2015 | -0.28 EUR | 40.43% |
| 2014 | -0.47 EUR | 22.95% |
| 2013 | -0.61 EUR | 12.86% |
| 2012 | -0.70 EUR | -233.33% |
| 2011 | -0.21 EUR | 54.35% |
| 2010 | -0.46 EUR | -9.52% |
| 2009 | -0.42 EUR | -200.0% |
| 2008 | -0.14 EUR | 46.15% |
| 2007 | -0.26 EUR | -992.44% |
| 2006 | -0.02 EUR | 80.17% |
| 2005 | -0.12 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.18 EUR | -145.24% |
| 2024 Q1 | 0.42 EUR | 282.61% |
| 2023 Q2 | -0.12 EUR | 7.69% |
| 2023 Q4 | -0.23 EUR | 8.0% |
| 2023 Q3 | -0.25 EUR | -108.33% |
| 2023 FY | - EUR | 41.13% |
| 2023 Q1 | -0.13 EUR | 59.38% |
| 2022 Q4 | -0.32 EUR | -141.03% |
| 2022 Q1 | -0.24 EUR | -114.04% |
| 2022 FY | - EUR | -65.33% |
| 2022 Q3 | 0.78 EUR | 149.37% |
| 2022 Q2 | -1.58 EUR | -558.33% |
| 2021 Q2 | -0.64 EUR | -113.33% |
| 2021 Q3 | -1.60 EUR | -150.0% |
| 2021 Q4 | 1.71 EUR | 206.88% |
| 2021 FY | - EUR | -5.63% |
| 2021 Q1 | -0.30 EUR | -1210.04% |
| 2020 Q4 | -0.02 EUR | 94.55% |
| 2020 Q3 | -0.42 EUR | -55.56% |
| 2020 Q2 | -0.27 EUR | -1914.93% |
| 2020 FY | - EUR | -3636.84% |
| 2020 Q1 | -0.01 EUR | -278.67% |
| 2019 Q4 | 0.01 EUR | 1975.0% |
| 2019 Q1 | 0.05 EUR | -29.38% |
| 2019 Q2 | -0.08 EUR | -257.8% |
| 2019 Q3 | -0.00 EUR | 99.49% |
| 2019 FY | - EUR | -146.91% |
| 2018 Q1 | 0.02 EUR | 150.0% |
| 2018 FY | - EUR | 127.0% |
| 2018 Q4 | 0.07 EUR | 277.0% |
| 2018 Q3 | -0.04 EUR | -100.0% |
| 2018 Q2 | -0.02 EUR | -200.0% |
| 2017 Q1 | -0.02 EUR | 32.2% |
| 2017 FY | - EUR | 77.27% |
| 2017 Q4 | -0.04 EUR | 0.0% |
| 2017 Q3 | -0.04 EUR | -33.33% |
| 2017 Q2 | -0.03 EUR | -50.0% |
| 2016 Q1 | -0.07 EUR | -723.53% |
| 2016 FY | - EUR | -135.71% |
| 2016 Q4 | -0.03 EUR | 67.22% |
| 2016 Q3 | -0.09 EUR | 80.43% |
| 2016 Q2 | -0.46 EUR | -557.14% |
| 2015 Q3 | -0.08 EUR | 33.92% |
| 2015 Q4 | -0.01 EUR | 89.28% |
| 2015 FY | - EUR | 40.43% |
| 2015 Q2 | -0.12 EUR | -56.05% |
| 2015 Q1 | -0.08 EUR | 40.85% |
| 2014 FY | - EUR | 22.95% |
| 2014 Q4 | -0.13 EUR | -160.0% |
| 2014 Q3 | -0.05 EUR | 44.44% |
| 2014 Q2 | -0.09 EUR | 30.77% |
| 2014 Q1 | -0.13 EUR | 13.33% |
| 2013 Q3 | -0.19 EUR | 5.0% |
| 2013 FY | - EUR | 12.86% |
| 2013 Q1 | -0.12 EUR | 47.83% |
| 2013 Q2 | -0.20 EUR | -66.67% |
| 2013 Q4 | -0.15 EUR | 21.05% |
| 2012 Q4 | -0.23 EUR | -109.09% |
| 2012 Q3 | -0.11 EUR | 0.0% |
| 2012 FY | - EUR | -233.33% |
| 2011 FY | - EUR | 54.35% |
| 2010 FY | - EUR | -9.52% |
| 2009 FY | - EUR | -200.0% |
| 2008 FY | - EUR | 46.15% |
| 2007 FY | - EUR | -992.44% |
| 2006 FY | - EUR | 80.17% |
| 2005 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ABIONYX Pharma SA | -0.12 EUR | -508.333% |
| ABIVAX Société Anonyme | -3.43 EUR | 78.717% |
| Adocia SA | -1.91 EUR | 61.78% |
| Aelis Farma SA | -0.39 EUR | -87.179% |
| Biophytis S.A. | -12.55 EUR | 94.183% |
| Advicenne S.A. | -0.67 EUR | -8.955% |
| genOway Société anonyme | 0.17 EUR | 529.412% |
| IntegraGen SA | -0.03 EUR | -2718.533% |
| Medesis Pharma S.A. | -0.80 EUR | 8.75% |
| Neovacs S.A. | -0.00 EUR | -29100.0% |
| NFL Biosciences SA | -0.46 EUR | -58.696% |
| Plant Advanced Technologies SA | 0.07 EUR | 1142.857% |
| Quantum Genomics Société Anonyme | -0.09 EUR | -702.198% |
| Sensorion SA | -0.17 EUR | -329.412% |
| Theranexus Société Anonyme | -0.88 EUR | 17.045% |
| TME Pharma N.V. | -1.34 EUR | 45.522% |
| Valbiotis SA | -0.59 EUR | -23.729% |
| TheraVet SA | -0.49 EUR | -48.98% |
| Valerio Therapeutics Société anonyme | -0.15 EUR | -386.667% |
| DBV Technologies S.A. | -0.71 EUR | -2.817% |
| Genfit S.A. | -0.58 EUR | -25.862% |
| GeNeuro SA | -0.59 EUR | -23.729% |
| Innate Pharma S.A. | -0.09 EUR | -675.77% |
| Inventiva S.A. | -2.43 EUR | 69.959% |
| MaaT Pharma SA | -1.73 EUR | 57.803% |
| MedinCell S.A. | -0.88 EUR | 17.045% |
| Nanobiotix S.A. | -1.08 EUR | 32.407% |
| OSE Immunotherapeutics SA | -1.18 EUR | 38.136% |
| Poxel S.A. | -0.91 EUR | 19.78% |
| GenSight Biologics S.A. | -0.54 EUR | -35.185% |
| Transgene SA | -0.22 EUR | -231.818% |